Checkmate Pharmaceuticals Inc (CMPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 10,977 | 9,833 | 8,271 | 7,823 | 8,400 |
| Operating Income | -10,977 | -9,833 | -8,271 | -7,823 | -8,400 |
| Other Income | 47 | 4 | -77 | 22 | 439 |
| Pre-tax Income | -10,930 | -9,829 | -8,348 | -7,801 | -7,961 |
| Net Income Continuous | -10,930 | -9,829 | -8,348 | -7,801 | -7,961 |
| Net Income | $-10,930 | $-9,829 | $-8,348 | $-7,801 | $-7,961 |
| EPS Basic Total Ops | 10.17 | -0.84 | -7.37 | -6.45 | -6.48 |
| EPS Basic Continuous Ops | 7.72 | -0.72 | -5.61 | -5.24 | -5.33 |
| EPS Diluted Total Ops | 10.17 | -0.84 | -7.37 | -6.45 | -6.48 |
| EPS Diluted Continuous Ops | 7.72 | -0.72 | -5.61 | -5.24 | -5.33 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.84 | -7.37 | N/A | N/A |
| EBITDA(a) | $-10,977 | $-9,833 | $-8,271 | $-7,823 | $-8,400 |